View of Itolizumab as the First Line of Treatment in Moderate to Severe Chronic Plaque Psoriasis- A Case Report

Return to Article Details Itolizumab as the First Line of Treatment in Moderate to Severe Chronic Plaque Psoriasis- A Case Report Download Download PDF